Dabigatran etexilate capsule

DRUG3 trials

Sponsors

Boehringer Ingelheim, Dongyang Liu

Conditions

Health, SubjectiveHealthyNonvalvular Atrial Fibrillation

Phase 1

Bioavailability of Different Applications of Dabigatran in Healthy Volunteers

CompletedNCT02171611

Boehringer IngelheimHealthy

Start: 2009-03-31Updated: 2017-05-23

Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects

CompletedNCT02710630

Boehringer IngelheimHealthy

Start: 2016-03-22End: 2016-06-10Updated: 2017-11-06

Unknown Phase

Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects

Dongyang LiuHealth, Subjective, Nonvalvular Atrial Fibrillation

Start: 2022-08-15End: 2023-07-30Target: 36Updated: 2023-02-08

Related Papers

Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects.

2020-06-014 citations